Skip to main content
Burning Rock Biotech Limited (BNR)
NASDAQ: BNR · Real-Time Price · USD
16.65
-2.41 (-12.64%)
Apr 28, 2026, 4:00 PM EDT - Market closed

Burning Rock Biotech Revenue

In the year 2025, Burning Rock Biotech had annual revenue of 539.57M CNY with 4.60% growth. Burning Rock Biotech had revenue of 126.32M in the quarter ending December 31, 2025, with 0.23% growth.

Revenue (ttm)
539.57M CNY
Revenue Growth
+4.60%
P/S Ratio
2.32
Revenue / Employee
800,546 CNY
Employees
674
Market Cap
179.26M USD

Revenue Chart

* This company reports financials in CNY.

History

Fiscal Year End Revenue Change Growth
Dec 31, 2025539.57M23.75M4.60%
Dec 31, 2024515.82M-21.61M-4.02%
Dec 31, 2023537.44M-25.80M-4.58%
Dec 31, 2022563.24M55.38M10.90%
Dec 31, 2021507.86M77.96M18.13%
Dec 31, 2020 Pro Pro Pro
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Myriad Genetics 824.50M
OPKO Health 606.88M
Castle Biosciences 344.23M
Fulgent Genetics 322.67M
MDxHealth 107.88M
FONAR 106.03M
Prenetics Global 92.39M
Biodesix 88.50M
Revenue Rankings

BNR News

More News